Paperwork Before Potency: Auditing High-Strength CBD Brands Against the UK Novel Foods Register

High-strength CBD invites a natural focus on numbers: milligrams per millilitre, batch codes, certificate-of-analysis figures. Yet before those numbers can be trusted, a more prosaic question deserves an answer. Is the product actually represented in the UK's novel foods paperwork? For experienced buyers, the FSA's novel foods register is not a marketing badge. It is a first-pass credibility filter, and one that is especially useful when a brand's strongest SKU is also its most lucrative.

As of November 2026, the register remains a practical starting point for UK shoppers who want to separate documented products from undocumented ones. It does not replace laboratory analysis, and it does not rank quality. It does, however, tell you whether a brand has taken a basic regulatory step that ought to precede confident retail sale.

What the register is, and what it is not

The UK novel foods regime for CBD crystallised after the Food Standards Agency advised that CBD extracts should be treated as novel foods. The register that followed is an administrative record of applications and products moving through the authorisation process. It is not a safety certificate, a potency guarantee, or an endorsement of a brand's customer service.

That distinction matters. An entry may be described as awaiting validation, validated, or authorised. Validation is best understood as a completeness check: the application has been checked for the information required to progress. It is not a finding that the product is safe, lawful in every respect, or accurately labelled. Authorisation is the endpoint of the process, and it carries more weight. Between those poles sits the bulk of the market, which is why shoppers need to read status labels carefully rather than treating any appearance on the register as equivalent.

The register is also not always a brand-level seal. It may list applicants, products, or both. A brand can appear through one application while another product, flavour, or strength sits outside that scope. For high-strength CBD, this is the central audit problem.

Why potent SKUs are more likely to sit outside the paperwork

High-strength products are commercially attractive because they command higher prices and appeal to experienced users. They are also more likely to be introduced after an initial application, reformulated, rebranded, or sold under a separate sub-brand. A company may have listed a 500mg oil while later adding a 2,000mg or 3,000mg version. The lower-strength product may be documented; the potent one may not be.

There are structural reasons for this. Product ranges churn quickly. White-label manufacturing makes it easy to add strengths. Marketing language such as "new formula" or "maximum strength" can signal a change in composition or simply a change in positioning. In either case, the retail SKU on the shelf may not match the product described in the application. None of this proves illegality. It does mean the burden of verification shifts to the buyer.

At CBD Intense, the working principle is straightforward: the stronger the claim, the more carefully the paperwork should be checked.

Step one: identify the legal entity behind the brand

Begin with the seller's legal identity, not the trading name alone. Check the product label, the brand's terms and conditions, and any regulatory information on its website. Look for a company name and, where available, a company number. The register may use an applicant name that differs from the consumer-facing brand. A parent company, distributor, or contract manufacturer may be the applicant.

If a brand cannot or will not identify the legal entity behind its application, treat that as an audit finding rather than a dead end. It may be explained, but it should be explained.

Step two: match the product, not the logo

Once you have found a possible entry, compare like with like. Product name, format, flavour, pack size, and CBD content should all be considered. The most common error is matching total milligrams per bottle rather than concentration per millilitre. A 30ml bottle containing 1,000mg provides roughly 33mg/ml. A 10ml bottle containing 1,000mg provides roughly 100mg/ml. They are not the same product from a regulatory or practical standpoint.

For high-strength oils, compare mg per ml first, then total pack content. Check whether the register refers to oil, capsules, paste, or another format. A listed CBD oil does not automatically cover a capsule or a vape product. A listed natural flavour does not automatically cover mint. A listed 10ml bottle does not automatically cover a 30ml bottle.

Step three: read the status in context

A validated entry is more reassuring than a merely lodged one, but it is not the same as an authorised product. The status should be read alongside the date and the scope of the entry. If a product has been validated, ask what exactly was validated. If an entry is old, ask whether the current retail formulation still falls within it. If a brand says it is "on the register", ask which product and which strength.

This is not pedantry. It is the difference between a brand-level statement and a product-level fact. For a high-street shopper or an online buyer in the UK, the latter is the one that matters.

Step four: request the application reference

A credible brand should be able to point to the relevant entry or application reference without treating the request as an accusation. The answer should be specific: product name, strength, format, and applicant. If the response is a general assertion that "all our products are compliant", ask for the entry that covers the exact SKU you are considering. If the brand sells several strengths, ask whether each one is covered.

A useful question is: "Can you confirm that this exact product, at this CBD concentration and pack size, is within the scope of your novel foods application?" The wording is formal, but it is fair. It also creates a record.

Step five: keep the register in its place

Register checks sit alongside, not above, laboratory evidence. A product may have a plausible paper trail and still fail on potency accuracy, pesticide residues, heavy metals, or solvent residues. Conversely, a product absent from the register is not automatically contaminated; it is simply less documented. The sensible order is register first, certificate of analysis second, and brand behaviour third.

For high-strength CBD, that order matters because the margin for error is narrower. A 10 per cent oil and a 20 per cent oil may look similar on a shelf, but they are different products for dosing and for paperwork. The register helps you ask the right question before the milligram count does the persuading.

A short audit checklist for UK shoppers

Identify the applicant or legal entity. Locate the entry by brand and product name. Match the exact strength in mg/ml, the pack size, and the format. Read the status and its date. Ask the brand to confirm that the retail SKU is within scope. Cross-check the batch certificate separately. Record the date of your check, because entries and product ranges change.

That is not an unduly burdensome process. It is the minimum diligence appropriate to a potent product sold with health-adjacent claims. The register will not tell you which high-strength CBD oil is best. It will help you decide which brands have earned a closer look, and which have left the paperwork to do the marketing instead.